Zobrazeno 1 - 10
of 15
pro vyhledávání: '"DMEM, Dulbecco׳s modified Eagle׳s medium"'
Autor:
Qingsong Li, Yongjun Wang, Lu Zhong, Dongyang Zhao, Huicong Zhang, Haotian Zhang, Yanying Liu, Qiming Kan, Jin Sun, Zhonggui He, Zhenbao Li, Lu Xu
Publikováno v:
Acta Pharmaceutica Sinica B, Vol 9, Iss 2, Pp 397-409 (2019)
Acta Pharmaceutica Sinica. B
Acta Pharmaceutica Sinica. B
Hyaluronic acid (HA) is a natural ligand of tumor-targeted drug delivery systems (DDS) due to the relevant CD44 receptor overexpressed on tumor cell membranes. However, other HA receptors (HARE and LYVE-1) are also overexpressing in the reticuloendot
Publikováno v:
Acta Pharmaceutica Sinica. B
Acta Pharmaceutica Sinica B, Vol 9, Iss 2, Pp 279-293 (2019)
Acta Pharmaceutica Sinica B, Vol 9, Iss 2, Pp 279-293 (2019)
Over recent decades, many studies have reported that hypocrellin A (HA) can eliminate cancer cells with proper irradiation in several cancer cell lines. However, the precise molecular mechanism underlying its anticancer effect has not been fully defi
Autor:
Can, Hu, Xin, Zhang, Wenying, Wei, Ning, Zhang, Haiming, Wu, Zhenguo, Ma, Lingli, Li, Wei, Deng, Qizhu, Tang
Publikováno v:
Acta Pharmaceutica Sinica. B
Oxidative stress and cardiomyocyte apoptosis are involved in the pathogenesis of doxorubicin (DOX)-induced cardiotoxicity. Matrine is well-known for its powerful anti-oxidant and anti-apoptotic capacities. Our present study aimed to investigate the e
Publikováno v:
Acta Pharmaceutica Sinica B, Vol 8, Iss 6, Pp 889-899 (2018)
Acta Pharmaceutica Sinica. B
Acta Pharmaceutica Sinica. B
Interferons (IFNs) are cytokines with fundamental roles in resistance to infections, cancer and other diseases. Type-I IFNs, interferon α (IFN-α) and interferon β (IFN-β), act through a shared receptor complex (IFNAR) comprised of IFNAR1 and IFNA
Autor:
Zhiqiang, Zhang, Xiaoran, Guo, Kenneth K W, To, Zhen, Chen, Xiaona, Fang, Min, Luo, Chunling, Ma, Jianhua, Xu, Shirong, Yan, Liwu, Fu
Publikováno v:
Acta Pharmaceutica Sinica. B
Overexpressing of ATP-binding cassette (ABC) transporters is the essential cause of multidrug resistance (MDR), which is a significant hurdle to the success of chemotherapy in many cancers. Therefore, inhibiting the activity of ABC transporters may b
Autor:
Chung Yong Kim, Yoon Jun Kim, Jung Hwan Yoon, Su Jong Yu, Jeong Hoon Lee, Minjong Lee, Yuri Cho, Jeong-Ju Yoo, Dong Hyeon Lee, Eun Ju Cho
Publikováno v:
Acta Pharmaceutica Sinica B, Vol 5, Iss 6, Pp 544-553 (2015)
Acta Pharmaceutica Sinica. B
Acta Pharmaceutica Sinica. B
Fucoidan is a traditional Chinese medicine suggested to possess anti-tumor effects. In this study the anti-metastatic effects of fucoidan were investigated in vitro in human hepatocellular carcinoma (HCC) cells (Huh-7 and SNU-761) under normoxic and
Autor:
Ting-Ting Jong, Chih-Hsueh Yang, Wei-Li Hsu, Chi-Luan Wen, Shih-Lan Hsu, Poa-Chun Chang, Duen-Huey Tan
Publikováno v:
Journal of Ethnopharmacology
Ethnopharmacological relevance Peperomia sui Lin and Lu (Peperomia sui), a well-known Taiwanese folk medicine, has a broad range of biological effects, especially in treatment of upper respiratory tract diseases. However, no previous study has explor
Autor:
Hu C; Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan 430060, China.; Cardiovascular Research Institute of Wuhan University, Wuhan 430060, China.; Hubei Key Laboratory of Cardiology, Wuhan 430060, China., Zhang X; Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan 430060, China.; Cardiovascular Research Institute of Wuhan University, Wuhan 430060, China.; Hubei Key Laboratory of Cardiology, Wuhan 430060, China., Wei W; Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan 430060, China.; Cardiovascular Research Institute of Wuhan University, Wuhan 430060, China.; Hubei Key Laboratory of Cardiology, Wuhan 430060, China., Zhang N; Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan 430060, China.; Cardiovascular Research Institute of Wuhan University, Wuhan 430060, China.; Hubei Key Laboratory of Cardiology, Wuhan 430060, China., Wu H; Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan 430060, China.; Cardiovascular Research Institute of Wuhan University, Wuhan 430060, China.; Hubei Key Laboratory of Cardiology, Wuhan 430060, China., Ma Z; Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan 430060, China.; Cardiovascular Research Institute of Wuhan University, Wuhan 430060, China.; Hubei Key Laboratory of Cardiology, Wuhan 430060, China., Li L; Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan 430060, China.; Cardiovascular Research Institute of Wuhan University, Wuhan 430060, China.; Hubei Key Laboratory of Cardiology, Wuhan 430060, China., Deng W; Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan 430060, China.; Cardiovascular Research Institute of Wuhan University, Wuhan 430060, China.; Hubei Key Laboratory of Cardiology, Wuhan 430060, China., Tang Q; Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan 430060, China.; Cardiovascular Research Institute of Wuhan University, Wuhan 430060, China.; Hubei Key Laboratory of Cardiology, Wuhan 430060, China.
Publikováno v:
Acta pharmaceutica Sinica. B [Acta Pharm Sin B] 2019 Jul; Vol. 9 (4), pp. 690-701. Date of Electronic Publication: 2019 Mar 16.
Autor:
Li G; State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau 999078, China., Boyle JW; School of Chemistry, Monash University, Clayton 3800, Australia., Ko CN; Department of Chemistry, Hong Kong Baptist University, Hong Kong 999077, China., Zeng W; State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macau 999078, China., Wong VKW; State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macau 999078, China., Wan JB; State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau 999078, China., Chan PWH; School of Chemistry, Monash University, Clayton 3800, Australia.; Department of Chemistry, University of Warwick, Coventry CV4 7AL, UK., Ma DL; Department of Chemistry, Hong Kong Baptist University, Hong Kong 999077, China., Leung CH; State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau 999078, China.
Publikováno v:
Acta pharmaceutica Sinica. B [Acta Pharm Sin B] 2019 May; Vol. 9 (3), pp. 537-544. Date of Electronic Publication: 2019 Jan 30.
Autor:
Chang L; Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China., Hu Y; Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China., Fu Y; Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China., Zhou T; Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China., You J; Zhejiang Cancer Hospital, Hangzhou 310022, China., Du J; Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China., Zheng L; Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China., Cao J; Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China., Ying M; Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China., Dai X; Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China., Su D; Zhejiang Cancer Hospital, Hangzhou 310022, China., He Q; Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China., Zhu H; Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China., Yang B; Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.
Publikováno v:
Acta pharmaceutica Sinica. B [Acta Pharm Sin B] 2019 May; Vol. 9 (3), pp. 484-495. Date of Electronic Publication: 2019 Mar 02.